Enovis (ENOV) Change in Account Payables (2012 - 2026)
Enovis (ENOV) reported Change in Account Payables of $26.9 million for Q2 2026, up 541.85% year-over-year from $4.2 million in Q2 2025, and up 334.17% quarter-over-quarter from -$11.5 million in Q4 2025.
Enovis (ENOV) Change in Account Payables (2012 - 2026) Analysis & Trends
Enovis (ENOV) has 15 years of Change in Account Payables data on file, last reported at $26.9 million in Q2 2026.
- Change in Account Payables for Q2 2026 came in at $26.9 million, up 541.85% year-over-year; the trailing twelve-month figure through Apr 2026 was $21.6 million (down 27.95% YoY), and the FY2025 annual result was -$1.1 million, down 108.13% from the prior year.
- Change in Account Payables improved to $26.9 million in Q2 2026 per ENOV's latest filing, from -$11.5 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $26.9 million in Q2 2026 and troughed at -$46.0 million in Q4 2022.
- A 5-year average of $1.3 million and a median of $4.2 million in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2026: Change in Account Payables plunged 232.26% in 2022, then soared 541.85% in 2026.
- A 5-year view of Change in Account Payables shows it stood at -$46.0 million in 2022, then jumped by 112.48% to $5.7 million in 2023, then jumped by 343.91% to $25.5 million in 2024, then plunged by 145.05% to -$11.5 million in 2025, then surged by 334.17% to $26.9 million in 2026.
- Business Quant data shows ENOV's Change in Account Payables at $26.9 million in Q2 2026, -$11.5 million in Q4 2025, and -$12.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | 26.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 26.89 Mn |
| Apr 3, 2026 | 26.89 Mn |
| Dec 31, 2025 | -11.48 Mn |
| Dec 31, 2025 | -11.48 Mn |
| Oct 3, 2025 | -12.82 Mn |
| Oct 3, 2025 | -12.82 Mn |
| Jul 4, 2025 | 18.97 Mn |
| Jul 4, 2025 | 18.97 Mn |
| Apr 4, 2025 | 4.19 Mn |
| Apr 4, 2025 | 4.19 Mn |
| Dec 31, 2024 | 25.49 Mn |
| Dec 31, 2024 | 25.49 Mn |
| Sep 27, 2024 | -4.76 Mn |
| Sep 27, 2024 | -4.76 Mn |
| Jun 28, 2024 | 5.01 Mn |
| Jun 28, 2024 | 5.01 Mn |
| Mar 29, 2024 | -11.75 Mn |
| Mar 29, 2024 | -11.75 Mn |
| Dec 31, 2023 | 5.74 Mn |
| Dec 31, 2023 | 5.74 Mn |